汇宇制药-W
(688553)
| 流通市值：73.72亿 | | | 总市值：90.90亿 |
| 流通股本：3.44亿 | | | 总股本：4.24亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,284,936,992.77 | 2,089,490,559.98 | 1,981,653,478.45 | 2,328,244,429.04 |
| 交易性金融资产 | 323,672,181.61 | 523,967,718.72 | 763,287,541.45 | 688,592,298.58 |
| 应收票据及应收账款 | 80,059,323.63 | 60,705,084.35 | 56,459,503.79 | 55,547,492.94 |
| 其中：应收票据 | - | 1,073,003.49 | 280,600 | 1,632,394.95 |
| 应收账款 | 80,059,323.63 | 59,632,080.86 | 56,178,903.79 | 53,915,097.99 |
| 预付款项 | 54,170,088.55 | 51,756,984.44 | 40,183,521.56 | 19,934,582.35 |
| 其他应收款合计 | 4,276,814.7 | 4,100,171.65 | 14,567,998.86 | 2,529,110.22 |
| 存货 | 236,197,846.62 | 218,135,034.43 | 202,748,808.4 | 159,919,087.79 |
| 其他流动资产 | 93,039,595.6 | 102,159,677.66 | 92,604,779.83 | 89,581,217.04 |
| 流动资产合计 | 3,076,352,843.48 | 3,050,315,231.23 | 3,151,505,632.34 | 3,344,348,217.96 |
| 非流动资产: | | | | |
| 长期股权投资 | 89,990,832.7 | 89,990,832.7 | 89,664,618.91 | 89,664,618.91 |
| 其他非流动金融资产 | 62,432,882.93 | 64,373,993.36 | 69,529,440.76 | 76,074,128.45 |
| 固定资产 | 929,527,909.91 | 948,782,705.76 | 971,304,250.14 | 986,203,573.79 |
| 在建工程 | 513,786,198.1 | 508,188,920.51 | 504,657,219.83 | 528,714,584.02 |
| 使用权资产 | - | 325,492.69 | 943,264.75 | 1,561,036.81 |
| 无形资产 | 60,365,087.95 | 60,027,209.48 | 60,283,351.95 | 60,566,483.1 |
| 开发支出 | 52,794,643.32 | 40,085,247.26 | 30,930,605.69 | 25,703,405.18 |
| 长期待摊费用 | 384,068.13 | 614,509.05 | 844,949.97 | 1,075,390.89 |
| 递延所得税资产 | 47,702,283.29 | 45,032,583.54 | 39,347,363.11 | 24,469,013.75 |
| 其他非流动资产 | 42,900,900.83 | 27,987,223.21 | 30,433,439.35 | 27,246,305.7 |
| 非流动资产合计 | 1,799,884,807.16 | 1,785,408,717.56 | 1,797,938,504.46 | 1,821,278,540.6 |
| 资产总计 | 4,876,237,650.64 | 4,835,723,948.79 | 4,949,444,136.8 | 5,165,626,758.56 |
| 流动负债: | | | | |
| 短期借款 | 500,029,088.96 | 508,665,874.19 | 410,339,715.79 | 580,280,993.09 |
| 应付票据及应付账款 | 147,900,728.46 | 155,647,346.51 | 160,230,313.59 | 197,033,339.03 |
| 其中：应付票据 | 29,905,941.18 | 16,572,908.08 | 14,920,355 | 3,994,945 |
| 应付账款 | 117,994,787.28 | 139,074,438.43 | 145,309,958.59 | 193,038,394.03 |
| 预收款项 | 32,023.26 | - | 29,357.83 | 386,694.5 |
| 合同负债 | 97,362,245.28 | 92,119,130.8 | 65,003,153.99 | 54,329,772.89 |
| 应付职工薪酬 | 33,970,592.23 | 29,666,550.86 | 27,998,526.54 | 38,915,481.35 |
| 应交税费 | 10,368,247.96 | 12,850,779.72 | 4,837,667.88 | 6,419,729.36 |
| 其他应付款合计 | 287,266,827.98 | 264,206,778.16 | 252,952,983.12 | 256,190,338.9 |
| 一年内到期的非流动负债 | 376,260 | 374,886.91 | 1,654,203.23 | 1,640,520.02 |
| 其他流动负债 | 1,624,562.42 | 1,991,676.56 | 1,555,726.35 | 1,551,955.97 |
| 流动负债合计 | 1,078,930,576.55 | 1,065,523,023.71 | 924,601,648.32 | 1,136,748,825.11 |
| 非流动负债: | | | | |
| 递延收益 | 73,221,769.01 | 74,527,776.83 | 73,868,254.22 | 48,979,993.52 |
| 递延所得税负债 | 3,106,980.83 | 3,592,258.44 | 4,882,360.19 | 6,517,538.15 |
| 非流动负债合计 | 76,328,749.84 | 78,120,035.27 | 78,750,614.41 | 55,497,531.67 |
| 负债合计 | 1,155,259,326.39 | 1,143,643,058.98 | 1,003,352,262.73 | 1,192,246,356.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 423,600,000 | 423,600,000 | 423,600,000 | 423,600,000 |
| 资本公积 | 2,487,295,700.22 | 2,487,295,700.22 | 2,487,295,700.22 | 2,487,295,700.22 |
| 减:库存股 | 30,020,576.71 | 30,020,576.71 | 30,020,576.71 | 30,020,576.71 |
| 其他综合收益 | -10,353,271.02 | -10,725,102 | -8,844,351.05 | -8,241,372.69 |
| 盈余公积 | 152,803,980.38 | 152,803,980.38 | 152,803,980.38 | 152,803,980.38 |
| 未分配利润 | 707,581,720.17 | 677,665,878.36 | 927,980,229.38 | 953,606,714.68 |
| 归属于母公司股东权益合计 | 3,730,907,553.04 | 3,700,619,880.25 | 3,952,814,982.22 | 3,979,044,445.88 |
| 少数股东权益 | -9,929,228.79 | -8,538,990.44 | -6,723,108.15 | -5,664,044.1 |
| 股东权益合计 | 3,720,978,324.25 | 3,692,080,889.81 | 3,946,091,874.07 | 3,973,380,401.78 |
| 负债和股东权益合计 | 4,876,237,650.64 | 4,835,723,948.79 | 4,949,444,136.8 | 5,165,626,758.56 |
| 公告日期 | 2025-10-30 | 2025-08-30 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |